BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18298592)

  • 1. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload.
    Tobian AA; Sokoll LJ; Tisch DJ; Ness PM; Shan H
    Transfusion; 2008 Jun; 48(6):1143-50. PubMed ID: 18298592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload.
    Zhou L; Giacherio D; Cooling L; Davenport RD
    Transfusion; 2005 Jul; 45(7):1056-63. PubMed ID: 15987348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill.
    Li G; Daniels CE; Kojicic M; Krpata T; Wilson GA; Winters JL; Moore SB; Gajic O
    Transfusion; 2009 Jan; 49(1):13-20. PubMed ID: 18954397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
    Korse CM; Taal BG; de Groot CA; Bakker RH; Bonfrer JM
    J Clin Oncol; 2009 Sep; 27(26):4293-9. PubMed ID: 19667278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.
    Boswood A; Dukes-McEwan J; Loureiro J; James RA; Martin M; Stafford-Johnson M; Smith P; Little C; Attree S
    J Small Anim Pract; 2008 Jan; 49(1):26-32. PubMed ID: 18005104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-associated circulatory overload-a systematic review of diagnostic biomarkers.
    Klanderman RB; Bosboom JJ; Migdady Y; Veelo DP; Geerts BF; Murphy MF; Vlaar APJ
    Transfusion; 2019 Feb; 59(2):795-805. PubMed ID: 30488959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptides for the evaluation of exercise intolerance.
    Mueller C; Maeder MT; Christ A; Reichlin T; Staub D; Noveanu M; Breidthardt T; Potocki M; Brutsche MH
    Am J Med; 2009 Mar; 122(3):265-72. PubMed ID: 19272488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria.
    Porcel JM; Chorda J; Cao G; Esquerda A; Ruiz-González A; Vives M
    Respirology; 2007 Sep; 12(5):654-9. PubMed ID: 17875051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical utility of NT-proBNP, a new biomarker of cardiac function and heart failure].
    Ishii J
    Rinsho Byori; 2008 Apr; 56(4):316-21. PubMed ID: 18516966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
    Guo Q; Bárány P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
    Am J Nephrol; 2009; 29(6):516-23. PubMed ID: 19077418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac stress biomarkers after red blood cell transfusion in patients at risk for transfusion-associated circulatory overload: a prospective observational study.
    Callum JL; Cohen R; Cressman AM; Strauss R; Armali C; Lin Y; Pendergrast J; Lieberman L; Scales DC; Skeate R; Ross H; Cserti-Gazdewich C
    Transfusion; 2018 Sep; 58(9):2139-2148. PubMed ID: 30204946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients.
    Berdal JE; Stavem K; Omland T; Hall C; Smith-Erichssen N
    Acta Anaesthesiol Scand; 2008 Oct; 52(9):1265-72. PubMed ID: 18823467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
    Cortés R; Otero MR; Morillas P; Roselló-Lletí E; Grigorian L; Martínez-Dolz L; de Burgos FG; Calabuig JR; Soria F; Lozano T; Portolés M; Bertomeu V
    Am J Hypertens; 2008 Jul; 21(7):820-5. PubMed ID: 18443568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.